Managing medicines-related continuity of care: the views of a range of prescribers in New Zealand general practice
C. Julie Wells 1 2 * , Lynn McBain 1 , Lesley Gray
1
1
2
Abstract
Continuity of care is considered vital to achieving high-quality health care. Traditionally, general practitioners have played a key role in managing continuity of care and have largely been accountable for prescribing decision-making in primary care. Following prescribing legislation changes, a range of health disciplines make decisions regarding medicines in the general practice setting. To date, few studies have investigated how different prescribing disciplines view the management of medicines-related continuity of care. Understanding the views of these clinicians is important to achieving safe, effective and equitable outcomes from medicines.
The purpose of this study was to explore the views of general practitioners, nurse prescribers and pharmacist prescribers about their role in managing medicines-related continuity of care.
Qualitative, semi-structured in-depth interviews were undertaken with 16 prescribers based in eight North Island (New Zealand) general practices. Interviews were transcribed verbatim and analysed thematically using an inductive approach.
Three key themes were identified from data analysis: a patient-focused approach; interdisciplinary teamwork; and optimising the medicine regimen.
Prescribers in this study identify the important connection between continuity of care and achieving good outcomes from medicines. Good patient–prescriber relationships and ongoing interdisciplinary relationships across all health settings are considered essential to medicines-related continuity of care. Prescribers experience challenges associated with increasing multimorbidity, medicines complexities and fragmentation of clinical records.
Keywords: continuity of care, general practitioners, non-medical prescriber, nursing roles, pharmacy services, prescriber, prescription medications, primary health care.
References
1 World Health Organization. Continuity and coordination of care: a practice brief to support implementation of the WHO framework on integrated people-centred health services. Geneva: World Health Organization; 2018. Available at https://www.who.int/publications/i/item/9789241514033
2 Reid R, Haggerty J, McKendry R. Defusing the confusion: concepts and measures of continuity of health care. Canadian Health Services Research Foundation; 2002. Available at https://www.researchgate.net/publication/245856177
3 Rogers J, Curtis P. The concept and measurement of continuity in primary care. Am J Public Health 1980; 70(2): 122-127.
| Crossref | Google Scholar | PubMed |
4 Saultz JW. Defining and measuring interpersonal continuity of care. Ann Fam Med 2003; 1(3): 134-143.
| Crossref | Google Scholar | PubMed |
5 Haggerty JL, Reid RJ, Freeman GK, et al. Continuity of care: a multidisciplinary review. BMJ 2003; 327: 1219-1221.
| Crossref | Google Scholar | PubMed |
6 World Health Organization. Preventing chronic diseases: a vital investment. World Health. Geneva: World Health Organization; 2005. Available at https://apps.who.int/iris/bitstream/handle/10665/43314/9241563001_eng.pdf?sequence=1&isAllowed=y
7 New Zealand Government. Medicines (Designated Pharmacist Prescribers) Regulations 2013. Parliamentary Counsel Office; 2013. Available at http://www.legislation.govt.nz/regulation/public/2013/0237/4.0/whole.html
8 New Zealand Government. Medicines (Designated Prescriber: Nurse Practitioners) Regulations 2005. Parliamentary Counsel Office; 2005. Available at https://www.legislation.govt.nz/regulation/public/2005/0266/latest/whole.html
9 New Zealand Government. Medicines (Designated Prescriber—Registered Nurses) Regulations 2016. Parliamentary Counsel Office; 2016. Available at https://www.legislation.govt.nz/regulation/public/2016/0140/11.0/whole.html
10 Raghunandan R, Tordoff J, Smith A. Non-medical prescribing in New Zealand: an overview of prescribing rights, service delivery models and training. Ther Adv Drug Saf 2017; 8(11): 349-360.
| Crossref | Google Scholar | PubMed |
11 World Health Organization. Medication without harm: WHO global patient safety challenge. Geneva: World Health Organization; 2017. Available at https://www.who.int/initiatives/medication-without-harm.
12 World Health Organization. Medication safety in polypharmacy: technical report. Geneva: World Health Organization; 2019. Available at https://www.who.int/publications/i/item/WHO-UHC-SDS-2019.11
13 World Health Organization. Promoting rational use of medicines. Geneva: World Health Organization; 2022. Available at https://www.who.int/activities/promoting-rational-use-of-medicines
14 Leitch S, Dovey SM, Cunningham WK, et al. Medication-related harm in New Zealand general practice: a retrospective records review. Br J Gen Pract 2021; 71(709): e626-e633.
| Crossref | Google Scholar | PubMed |
15 DuGoff EH, Bandeen-Roche K, Anderson GF. Relationship between continuity of care and adverse outcomes varies by number of chronic conditions among older adults with diabetes. J Comorb 2016; 6(2): 65-72.
| Crossref | Google Scholar | PubMed |
16 Gruneir A, Bronskill SE, Maxwell CJ, et al. The association between multimorbidity and hospitalization is modified by individual demographics and physician continuity of care: a retrospective cohort study. BMC Health Serv Res 2016; 16: 154.
| Crossref | Google Scholar | PubMed |
17 Maciejewski ML, Powers BJ, Sanders LL, et al. The intersection of patient complexity, prescriber continuity and acute care utilization. J Gen Intern Med 2014; 29(4): 594-601.
| Crossref | Google Scholar | PubMed |
18 Anthierens S, Tansens A, Petrovic M, et al. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract 2010; 11: 65.
| Crossref | Google Scholar | PubMed |
19 Austad B, Hetlevik I, Mjølstad BP, et al. Applying clinical guidelines in general practice: a qualitative study of potential complications. BMC Fam Pract 2016; 17: 92.
| Crossref | Google Scholar | PubMed |
20 Moffat K, Mercer SW. Challenges of managing people with multimorbidity in today’s healthcare systems. BMC Fam Pract 2015; 16: 129.
| Crossref | Google Scholar | PubMed |
21 Stokes T, Tumilty E, Doolan-Noble F, et al. Multimorbidity, clinical decision making and health care delivery in New Zealand primary care: a qualitative study. BMC Fam Pract 2017; 18: 51.
| Crossref | Google Scholar | PubMed |
22 Guthrie B, Payne K, Alderson P, et al. Adapting clinical guidelines to take account of multimorbidity. BMJ 2012; 345: e6341.
| Crossref | Google Scholar |
23 Jones JA, Reeve CA. Factors influencing the use of clinical guidelines by general practitioners working in a setting of complex multimorbidity: a case study by interviews. BMC Fam Pract 2018; 19: 157.
| Crossref | Google Scholar | PubMed |
24 Clarke V, Braun V. Thematic analysis. J Posit Psychol 2017; 12(3): 297-298.
| Crossref | Google Scholar |
25 Jackson J, MacKean G, Cooke T, et al. Patient and provider experiences with relationship, information, and management continuity. Patient Exp J 2017; 4(3): 38-47.
| Crossref | Google Scholar |
26 Kamimura A, Higham R, Rathi N, et al. Patient–provider relationships among vulnerable patients: the association with health literacy, continuity of care, and self-rated health. J Patient Exp 2020; 7(6): 1450-1457.
| Crossref | Google Scholar | PubMed |
27 Damarell RA, Morgan DD, Tieman JJ. General practitioner strategies for managing patients with multimorbidity: a systematic review and thematic synthesis of qualitative research. BMC Fam Pract 2020; 21: 131.
| Crossref | Google Scholar | PubMed |
28 Maciejewski ML, Hammill BG, Bayliss EA, et al. Prescriber continuity and disease control of older adults. Med Care 2017; 55(4): 405-410.
| Crossref | Google Scholar | PubMed |
29 Maciejewski ML, Hammill BG, Voils CI, et al. Prescriber continuity and medication availability in older adults with cardiometabolic conditions. SAGE Open Med 2018; 6: 2050312118757388.
| Crossref | Google Scholar | PubMed |
30 National Institute for Health and Care Excellence. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. 2015. Available at https://www.nice.org.uk/guidance/ng5
31 Cope LC, Abuzour AS, Tully MP. Nonmedical prescribing: where are we now? Ther Adv Drug Saf 2016; 7(4): 165-172.
| Crossref | Google Scholar | PubMed |
32 Jorgenson D, Laubscher T, Lyons B, et al. Integrating pharmacists into primary care teams: barriers and facilitators. Int J Pharm Pract 2014; 22: 292-299.
| Crossref | Google Scholar | PubMed |
33 Maddox C, Halsall D, Hall J, et al. Factors influencing nurse and pharmacist willingness to take or not take responsibility for non-medical prescribing. Res Soc Admin Pharm 2016; 12: 41-55.
| Crossref | Google Scholar | PubMed |
34 Agarwal G, Crooks VA. The nature of informational continuity of care in general practice. Br J Gen Pract 2008; 2008 58: e17-e24.
| Crossref | Google Scholar | PubMed |
35 Braund R, Coulter CV, Bodington A, et al. Drug related problems identified by community pharmacists on hospital discharge prescriptions in New Zealand. Int J Clin Pharm 2014; 36: 498-502.
| Crossref | Google Scholar | PubMed |
36 Ozavci G, Bucknall T, Woodward-Kron R, et al. A systematic review of older patients’ experiences and perceptions of communication about managing medication across transitions of care. Res Soc Admin Pharm 2021; 17: 273-291.
| Crossref | Google Scholar | PubMed |
37 Strehlau AG, Larsen MD, Søndergaard J, et al. General practitioners’ continuation and acceptance of medication changes at sectorial transitions of geriatric patients - A qualitative interview study. BMC Fam Pract 2018; 19: 168.
| Crossref | Google Scholar | PubMed |
